We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+1.04%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$873M
AUM Growth
-$174M
Cap. Flow
-$174M
Cap. Flow %
-19.94%
Top 10 Hldgs %
17.05%
Holding
1,175
New
428
Increased
111
Reduced
142
Closed
493

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$38M
2
TSLA icon
Tesla
TSLA
+$17.7M
3
ULTA icon
Ulta Beauty
ULTA
+$12M
4
ADBE icon
Adobe
ADBE
+$11.3M
5
SHOP icon
Shopify
SHOP
+$9.5M

Top Sells

Rank Stock Value
1
GM icon
General Motors
GM
+$12.5M
2
MU icon
Micron Technology
MU
+$11M
3
CSCO icon
Cisco
CSCO
+$10.9M
4
DELL icon
Dell
DELL
+$10.6M
5
FDX icon
FedEx
FDX
+$10.1M

Sector Composition

Rank Sector Weight
1 Technology 24.87%
2 Consumer Discretionary 15.2%
3 Industrials 10.77%
4 Healthcare 9.97%
5 Financials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
776
Cameco
CCJ
$46.3B
-39,100
Closed -$1.69M
CCOI icon
777
Cogent Communications
CCOI
$495M
-5,830
Closed -$381K
CCRN
778
DELISTED
Cross Country Healthcare
CCRN
-10,400
Closed -$195K
CENTA icon
779
Central Garden & Pet Co Class A
CENTA
$2.36B
-11,315
Closed -$418K
CF icon
780
CF Industries
CF
$19B
-28,654
Closed -$2.38M
CFLT
781
DELISTED
Confluent
CFLT
-202,000
Closed -$6.17M
CG icon
782
Carlyle Group
CG
$17.5B
-25,876
Closed -$1.21M
CGC
783
Canopy Growth
CGC
$454M
-12,200
Closed -$105K
CHGG icon
784
Chegg
CHGG
$89M
-75,313
Closed -$570K
CHRS icon
785
Coherus Oncology
CHRS
$226M
-23,559
Closed -$56.3K
CHX
786
DELISTED
ChampionX
CHX
-29,322
Closed -$1.05M
CIGI icon
787
Colliers International
CIGI
$5.26B
-1,674
Closed -$205K
CIM
788
Chimera Investment
CIM
$964M
-8,400
Closed -$116K
CIVI
789
DELISTED
Civitas Resources
CIVI
-20,800
Closed -$1.58M
CLDX icon
790
Celldex Therapeutics
CLDX
$3.18B
-11,200
Closed -$470K
CLF icon
791
Cleveland-Cliffs
CLF
$6.75B
-36,900
Closed -$839K
CLOV icon
792
Clover Health Investments
CLOV
$2.25B
-179,000
Closed -$142K
CLS icon
793
Celestica
CLS
$40B
-36,926
Closed -$1.66M
CM icon
794
Canadian Imperial Bank of Commerce
CM
$104B
-7,500
Closed -$380K
CMCSA icon
795
Comcast
CMCSA
$93.7B
-156,700
Closed -$6.79M
CMPR icon
796
Cimpress
CMPR
$2.17B
-3,852
Closed -$341K
CNMD icon
797
CONMED
CNMD
$1.51B
-6,104
Closed -$489K
CNO icon
798
CNO Financial Group
CNO
$5.1B
-7,374
Closed -$203K
CNX icon
799
CNX Resources
CNX
$5.34B
-58,587
Closed -$1.39M
CNXC icon
800
Concentrix
CNXC
$1.72B
-9,936
Closed -$658K

Similar funds

Bayesian Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Bayesian Capital Management held 1,175 positions worth $873M, down 17% from $1.05B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Bayesian Capital Management withdrew a net $174M in Q2 2024, closing 493 positions and reducing 142 holdings. Its most notable exit was Micron Technology, an estimated $11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Bayesian Capital Management opened a new position in State Street SPDR S&P 500 ETF Trust worth $39.5M.

  • Bayesian Capital Management's largest Q2 2024 buy was State Street SPDR S&P 500 ETF Trust: 72,600 shares worth $39.5M.
  • Bayesian Capital Management added most to Accenture in Q2 2024, an estimated $6.1M increase.
  • Bayesian Capital Management's biggest Q2 2024 reduction was General Motors, cutting an estimated $12.5M.
  • Bayesian Capital Management fully exited Micron Technology in Q2 2024, selling an estimated $11M.
  • Bayesian Capital Management's ten largest holdings make up 17% of its $873M portfolio in Q2 2024.
  • Bayesian Capital Management opened 428 new positions and closed 493 in Q2 2024.
  • Bayesian Capital Management's portfolio value fell 17% quarter-over-quarter to $873M.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.